- 59% of U.S. dogs are overweight or obese (APOP).
- PRIOME® MH reduced postprandial blood glucose significantly in clinical trials.
- $158 billion: U.S. pet industry market size in 2025.
Experts agree that ADM's PRIOME® Metabolic Health Postbiotic represents a significant advancement in preventative pet care, bridging human and animal health science with scientifically validated metabolic benefits.
Science of Pet Longevity: Postbiotic Nabs Top Innovation Award
LOS ANGELES, CA – August 06, 2026 – In a significant nod to the growing sophistication of pet wellness, ADM's PRIOME® Metabolic Health (MH) Postbiotic has been named “Dog Preventative Product of the Year” at the 2026 Pet Innovation Awards. The award signals a pivotal shift in companion animal care, moving beyond basic nutrition to embrace scientifically validated ingredients that target the root causes of chronic health issues, particularly those related to aging and metabolism.
ADM, a global leader in nutrition and agricultural processing, received the honor for its innovative postbiotic ingredient designed to support metabolic balance in dogs. The 8th annual Pet Innovation Awards, an independent platform recognizing excellence in the booming pet care industry, highlighted PRIOME® MH for its science-backed approach to a problem plaguing a majority of household pets: metabolic decline.
“We are pleased to accept this award from Pet Innovation,” said James Kyffin, Global Director of Pet and Animal Wellbeing at ADM. “Pet owners increasingly view their animals as family members and are seeking proactive, preventive solutions to support healthy aging and long-term wellbeing.”
This award is more than just a corporate accolade; it serves as a marker for a broader trend where the lines between human and animal health science are blurring, with pet owners demanding the same level of preventative care for their companions as they do for themselves.
A New Frontier in Pet Wellness: The Science of Postbiotics
At the heart of this innovation is the postbiotic itself—a term rapidly gaining traction in nutritional science. While many consumers are familiar with probiotics, the live beneficial bacteria found in yogurt and other fermented foods, postbiotics represent the next evolutionary step. The International Scientific Association for Probiotics and Prebiotics (ISAPP) defines a postbiotic as a “preparation of inanimate microorganisms and/or their components that confers a health benefit on the host.”
Unlike live probiotics, which can be sensitive to manufacturing processes, ADM’s PRIOME® MH is a heat-treated version of a specific bacterial strain, Bifidobacterium animalis subsp. lactis CECT 8145. This inactivation process makes the ingredient remarkably stable, allowing it to be incorporated into a wide variety of pet food formats—from extruded dry kibble and baked treats to soft chews and wet foods—without losing its functional benefits. This stability solves a major logistical challenge for pet food manufacturers seeking to deliver reliable, science-backed solutions.
The core advantage of a postbiotic lies in its direct action. It delivers the beneficial compounds produced by microorganisms without requiring the bacteria to colonize the gut, offering a consistent and predictable physiological effect. This makes it a particularly safe and effective option, even for pets with sensitive digestive systems.
Clinical Validation and Real-World Impact
The recognition from the Pet Innovation Awards is underpinned by rigorous scientific validation. The claims for PRIOME® MH are supported by a peer-reviewed clinical study published in the scientific journal Animals. The randomized, double-blind, placebo-controlled trial—the gold standard in clinical research—investigated the effects of the postbiotic on a group of Labrador Retrievers undergoing periods of metabolic stress.
The results were compelling. Dogs supplemented with PRIOME® MH showed a significant reduction in postprandial blood glucose, the spike in blood sugar that occurs after a meal. Uncontrolled glucose spikes are a key factor in the development of insulin resistance and other metabolic disorders. By helping to maintain normal blood glucose levels, the postbiotic supports overall metabolic stability.
Furthermore, the study revealed other crucial benefits. The supplemented group exhibited a reduction in gamma-glutamyl transferase (GGT), a key enzyme that, when elevated, can indicate liver stress—a common issue in overweight animals. Researchers also observed favorable modulation of gut hormones responsible for regulating appetite and glucose metabolism. These multi-faceted effects demonstrate a holistic approach to metabolic wellness.
“By understanding how the gut microbiome influences metabolic health, ADM supports healthier, longer lives for pets,” commented Travis Grant, Managing Director of the Independent Innovation Awards. “PRIOME® MH’s ability to support multiple interconnected aspects of metabolic health helps to move beyond symptom management to address root causes.”
Tackling the Canine Obesity and Metabolic Health Crisis
The development of PRIOME® MH is a direct response to a growing and alarming health crisis among companion animals. According to the Association for Pet Obesity Prevention (APOP), an estimated 59% of dogs in the United States are classified as overweight or obese. This epidemic is a primary driver of numerous health complications, including diabetes, arthritis, liver disease, and a decreased lifespan.
For decades, the primary strategy for managing pet weight has been a simple formula: calorie restriction and increased exercise. While important, this approach often fails to address the complex underlying physiological imbalances. ADM’s innovation represents a new paradigm that acknowledges the intricate connection between the gut microbiome, inflammation, and metabolic function.
The product is designed to provide proactive support, helping to maintain metabolic balance before serious health issues arise. This is particularly crucial for aging pets, who are more susceptible to metabolic decline. As Kyffin noted, ADM is committed to investing in R&D to develop “next-generation solutions that address critical areas of companion animal wellbeing,” a strategy that directly aligns with consumer demand for products that enhance not just lifespan, but healthspan.
The “Humanization” of Pets Drives Market Innovation
The success of a highly scientific product like PRIOME® MH reflects a powerful cultural and economic shift: the “humanization” of pets. As owners increasingly treat their pets as integral family members, they are investing heavily in their health and wellness. This trend has propelled the U.S. pet industry to a staggering $158 billion market in 2025, with continued growth projected for 2026.
Industry awards like the Pet Innovation Awards serve as a crucial barometer for this evolving market. The judging panel, composed of independent industry experts, evaluates products on criteria such as innovation, practical benefits, and their potential to influence future trends. ADM’s win in the “Dog Preventative Product of the Year” category underscores a clear market direction toward functional, science-driven, and preventative wellness solutions.
This shift is forcing the entire pet food industry to innovate, moving from basic sustenance to functional nutrition that promises tangible health outcomes. With its deep R&D capabilities and portfolio of nature-derived ingredients, ADM is strategically positioned to lead this change. The award for PRIOME® MH is not just a win for one product, but a testament to a future where advanced science is harnessed to help pets live longer, healthier, and more vibrant lives.
Topics & Related
Animal Health
📝 This article is still being updated
Are you a relevant expert who could contribute your opinion or insights to this article? We'd love to hear from you. We will give you full credit for your contribution.
Contribute Your Expertise →